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1. Introduction 
Administration of vitamin K-antagonists induces 
the appearance of abnormal clotting factors in the 
blood (man, cow) or in the liver (rat). These abnormal 
clotting factors (descarboxyfactors) contain glutamic 
acid (Glu) residues instead of the y-carboxyglutamic 
acid (Gla) residues, which occur in normal clotting 
factors [ 11. In human and bovine plasma -90% of the 
abnormal proteins consists of descarboxyprothrombin. 
Attempts to identify the rat liver abnormal proteins 
have been done in an in vitro vitamin K-dependent 
carboxylating enzyme system (carboxylase) and it was 
shown that only 25% of the carboxylated endogenous 
substrates bound to antiprothrombin antibodies [2]. 
Here, we describe the preparation of vitamin 
K-dependent carboxylase from the livers of warfarin- 
treated cows and the results of our investigations con- 
cerning the distribution of the various clotting factor 
precursors in this enzyme system. 
2. Materials and methods 
2.1. Preparation of coagulation factors and antibodies 
Bovine prothrombin was prepared and purified as 
in [3], factor IX as in [4] and factor X according to 
[S]. The various coagulation factors were detected 
with the aid of one-stage coagulation assays [6-81. 
Antibodies against these proteins were raised in goats 
and extracted from the various sera by immunospecific 
adsorption to the respective Sepharose-bound antigens. 
The purified antibodies were eluted from the solid 
phase with 3 M NaCNS and gave single precipitation 
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lines against normal reference plasma in an Ouchterlony 
diffusion test [9]. These antibodies were coupled to 
CNBr-activated Sepharose (Pharmacia). Antipro- 
thrombin-Sepharose slurry (1 ml) was able to 
neutralize the prothrombin content of 8 ml plasma. 
For antifactor IX-Sepharose and antifactor X-Sepha- 
rose these figures were 5 ml and 9 ml, respectively. 
The various antibody preparations did not bind detect- 
able amounts of any of the other coagulation factors. 
2.2. Preparation o,f carboxylase 
One year old cows were anticoagulated by the oral 
administration of warfarin (Sigma, 10 mg/kg daily) 
during 1 week. Cows were slaughtered and micro- 
somes were prepared from the livers of normal and 
anticoagulated animals as in [lo]. The crude micro- 
somes were suspended in a buffer containing 0.05 M 
KCl, 0.02 M Tris-HCl (pH 7.5) and 0.1% Triton 
X-100. After centrifugation at 100 000 X g for 1 h 
the pellet was solubilized by adding a buffer contain- 
ing 1 M KCl, 0.02 M Tris-HCl (pH 7.5), 1 mM DTT, 
0.5 mM EDTA and 0.5% Triton X-100. The final pro- 
tein concentration was 15 mg/ml and insoluble mate- 
rial was removed by centrifugation (140 000 X g for 
1.5 h). The supernatant of this run was designated as 
soluble carboxylase. 
2.3, Measurement of carbox_vlase activity 
Unless indicated otherwise the vitamin K-depen- 
dent incorporation of 14C0, was measured by incu- 
bating soluble carboxylase (1 mg protein) and 20 &i 
NaH14C03 (Radiochemical Centre, Amersham) in 
reaction mixtures (0.25 ml) containing 0.15 M NaCl, 
0.02 M Tris-HCl (pH 7 .S), 1 mM DTT, 0.2 mM EDTA 
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and 0.2% Triton X-100. The reaction was started by 
adding 15 pg chemically reduced vitamin Kr [IO] 
and the mixtures were incubated for 1 h at 25°C in 
sealed tubes. The reaction was stopped with 2 ml tri- 
chloroacetic acid (10%) and the precipitates were 
washed and counted. The acid-soluble substrate Phe- 
Leu-Glu-Glu-Leu (FLEEL) was prepared accord- 
ing to [ 1 l] and when it was present in the reaction 
mixtures the trichloroacetic acid supernatants were 
degassed at elevated temperatures before counting. 
2.4. Gel electrophoresis and protein determination 
SDS-polyacrylamide gel electrophoresis was per- 
formed according to [ 121. Gels containing labeled 
products were sliced with a Gilson gel slicer and 
counted. Non-labeled gels were stained with Coomassie 
blue. Protein concentrations were determined accord- 
ing to [ 131. 
3. Results and discussion 
In soluble rat carboxylase the incorporation of 
14C02 in endogenous substrates is increased at least 
20-fold when the rats are treated with warfarin 18 h 
before preparing the liver homogenates. We observed 
that in soluble carboxylase obtained from warfarin- 
treated cows the carboxylation of endogenous sub- 
strate was 16-fold higher (80 000 dpm/g liver) than in 
carboxylase from normal cows (5000 dpm/g liver). 
These results suggested, that also in the cow liver some 
endogenous substrate (presumably clotting factor pre- 
cursors) is accumulated during warfarin treatment 
and we therefore used carboxylase from anticoagulated 
cows for our studies concerning the nature of the 
bovine endogenous substrate. 
Because of the presence of abundant proteolytic 
activity in bovine liver homogenates a direct deter- 
mination of clotting factor precursors (e.g., with snake 
venoms) was not possible. In order to establish the 
nature of the endogenous substrate we therefore 
analyzed the 14C-labeled products that were formed 
during the carboxylation reaction. The analysis was 
performed by adsorption to immobilized antibodies 
and, as is shown in table 1, the main part (69%) of the 
reaction product consists of factor X-like material, 
whereas antiprothrombin and antifactor IX bound 
21 and 8% of the incorporated label, respectively. 
In a second experiment the factor X-like material was 
eluted from the antibodies and characterized further 
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Table 1 
Sepharose- “C0, incorporated lJCO, incorporated 
linked into non-adsorbed into adsorbed 
adsorbant proteins proteins 
dpm/g liver 7n dpm/g liver ?? 
(a) Antipro- 
thrombin 62 638 78.7 16 812 21.2 
(b) Anti- 
factor X 23 452 29.5 55 090 69.2 
(c) Anti- 
factor IX 73 819 92.8 6181 7.8 
(d) a + b + c 9407 11.8 70 314 88.3 
(e) Albumin 76 321 95.9 204 0.3 
lmmunospecific adsorption of carboxylated reaction prod- 
ucts. Vitamm Kdependent incorporation of ‘“CO, was per- 
formed in standard reaction mixtures (1 ml). After incuba- 
tion for 1 h at 25”C, Sepharose-bound antibodies (0.4 ml 
slurry) were added to the various reaction mtxtures and the 
tubes were rotated end-overend overnight at 4°C. The Sepha- 
rose-beads were washed alternately 3 times with 1 M NaCl in 
0.1 M acetate buffer (pH 4.0) and with 1 M NaCl in 0.1 M 
borate buffer (pH 8.0). Subsequently they were elutcd with 
6 M urea m 2% SDS, dialyzed against 0.1 M NaCl and counted. 
Non-adsorbed reaction mixtures (100%) contained 79 588 
dpm/g liver. Doubling the amount of Sepharose-bound anti- 
bodies dtd not affect the amount of adsorbed proteins 
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Fig.1. SDS-polyacrylamtde gel electrophoresis of carboxylated 
endogenous substrates. Reaction mixtures (0.5 ml) were mcu- 
bated for 1 h at 25°C mixed with 0.5 ml antifactor XPScpha- 
rose and rotated end-over-end at 4°C overnight. The Sepharose 
was washed as described in the legend to table 1 and the 
labeled antigens were eluted with 3 M NaCNS and dialyzed 
against 0.15 M NaCl. The samples were incubated at 37°C for 
1 h with snake venoms as indicated and SDS was added to 1%~ 
final cont. (A) Non-reduced sample; (B) reduced sample; 
(C) non-reduced sampleafter treatment with RVVX; (D) sam- 
ple treated with RVVX before reduction. 
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with the aid of SDS--polyacrylamide gel electropho- 
resis before and after reduction of the samples (fig.1). 
The non-reduced samples (A) showed a single band 
withM, 55 000, which is in agreement with that of 
factor X [5,14]. The app. Mr of the reduced protein 
(B) was found to be 65 000, which is higher than in 
the non-reduced gels and which shows that the factor 
X-like material consists of one single polypeptide 
chain. It turned out that E. carinatus venom did not 
change the observed relative molecular masses (not 
shown). On the other hand the purified factor X-acti- 
vating enzyme from Russell’s viper venom (RVVX) 
induced a small amount of low Mr material (15 000) 
in the non-reduced gel (C), whereas in the reduced 
sample (D) nearly all highn/l, material had disappeared 
and was recovered at a position indicating an M, of 
25 000. We concluded that the factor X-like material 
is a factor X-precursor consisting of one polypeptide 
chain. 
After cleavage of this chain by RVV,, the mole- 
cule is held together by a disulfide bridge, which can 
be broken by reducing agents. Because the reaction 
mixture in which the carboxylation occurs is also 
slightly reducing, a small amount of low Mr material 
is observed in the non-reduced sample. The increase 
of the app. M, in the reduced gels seems to be almost 
entirely due to changes in the light-chain material. 
A similar observation was made for the light chain of 
factor X [ 14,151. As plasma factor X contains two 
peptide chains, in vivo the carboxylation of the pre- 
cursor probably precedes the conversion of one-chain 
factor X into two-chain factor X. 
Taking into consideration that in bovine plasma 
circulating prothrombin and factor X are 1.4 and 
0.28 FM, that their half-life times are 80 h and 30 h, 
respectively, and that factor X contains 2 more Gla 
residues than does prothrombin, it may be calculated 
that in vivo at least 1.5 more carboxylation reactions 
occur in prothrombin precursors than in factor X pre- 
cursors. The experiments described above demonstrate 
that this situation is reversed in the in vitro carboxyl- 
ating enzyme system. The relative abundance of fac- 
tor X precursors in the carboxylase complex may be 
caused by a relatively high affinity of carboxylase for 
this substrate. During the preparation of the liver 
microsomes unbound factor X precursors might then 
displace other clotting factor precursors, present in the 
enzyme complex. A second possibility is that the pro- 
thrombin precursors are more susceptible to proteolytic 
degradation which may occur during the preparation 
of the microsomes. The available data provide no basis 
for distinguishing between these possibilities. 
Since we knew that the endogenous substrate for 
the in vitro carboxylation reaction mainly consisted 
of precursors of factor X (69%) and prothrombin 
(2 l%), we started experiments in which we extracted 
the crude soluble carboxylase preparation with Sepha- 
rose-bound antibodies against factor X and prothrom- 
bin, respectively. It turned out that treatment with 
antiprothrombin removed 21% of the carboxylase 
activity, whereas antifactor X was able to bind as much 
as 62% of the total amount of carboxylase. A sub- 
stantial amount of carboxylase activity was recovered 
on the Sepharose beads and because most of the micro- 
somal proteins were removed by the washing proce- 
dure, the bound enzyme,complex had been purified 
considerably. Solid phase carboxylase was assayed in 
the absence of Triton X-100 since detergents trongly 
inhibit its activity, even at low concentration. 
A summary of the purification scheme is given in 
table 2. When we eluted the solid phase carboxylase 
with 2% SDS in 6 M urea it turned out that our most 
purified preparation still contained 8 different pro- 
teins, when analyzed on polyacrylamide gels. At this 
moment we do not know which of these proteins 
belong to the carboxylase complex. 
An advantage of the insolubilized enzyme is that it 
is stable even at elevated temperatures. At 37°C the 
carboxylation reaction occurred 3 times faster than at 
25’C and, in the presence of an excess of exogenous 
Table 2 
Stage Protein Spec. act. 
(mg) (dpmlmg) 
Recovery Purifi- 
(%) cation 
(-fold) 
Crude micro- 
somes 2400 1420 100 1 
Washed micro- 
somes 1800 2085 110 1.5 
Soluble car- 
boxylase 1100 3006 91 2.1 
Immobilized 
carboxylase 5 137 216 20 91 
~___ 
Purification of bovine vitamin K-dependent carboxylase. The 
protein content of immobilized carboxylase was determined 
after elution of the solid phase with 6 M urea in 2% SDS. The 
carboxylation of endogenous substrate was measured in the 
various carboxylase preparationsafter 1 h incubation at 25°C. 
When the carboxylase activity was measured with FLEEL the 
final purification was 115-fold 
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substrate, the reaction rate was constant for 22 hours. [41 
Thus far the only way to re-solubilize carboxylase 
was by allowing the carboxylation reaction to proceed. 
Preliminary experiments, in which the solid-phase car- 
boxylase was incubated in the presence of vitamin 
KHZ, FLEEL and NaHC03 showed that -30% of the 
enzyme activity could be regained in solution. Prepara- 
tions thus obtained were unstable, however, and the 
improvement of the elution procedure is a subject of 
current studies. 
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